Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-20-011261

President & CEO sold 8,448 shares at $22.35 ($188,813)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBIN HOWARD W President & CEO 2020-02-18 Sale −8,448 $22.35 $188,813 384,871 D: show line 1 in the form
Open-market sales · 8,448 sh · avg $22.35 · $188,813
Loading xslF345X03/doc4.xml…